Showing results (61-70 of 136) with videos related to
Sort By:
Pageof 14
Bone Marrow Transplantation|July 22, 2026
Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committeeMohammed Essa, Mattia Algeri, Mohsen Alzahrani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysisJohannes Schetelig, Anja van Biezen, Ronald Brand, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamideClaudio Praga, Jonas Bergh, Judith Bliss, et al.Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.The Lancet. Oncology|October 30, 2025
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines CommitteeJaime Sanz, Gesine Bug, Fabio Ciceri, et al.Blood|May 24, 2008
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)Emilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, et al.Blood|October 25, 2013
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHDAttilio Olivieri, Michele Cimminiello, Paolo Corradini, et al.Haematologica|August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working PartyFrancesco Onida, Ronald Brand, Anja van Biezen, et al.Blood|March 17, 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G CommitteeFrancesco Onida, Nico Gagelmann, Yves Chalandon, et al.Haematologica|October 16, 2012
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter studyLivio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.Pageof 14